Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%

Journal of Clinical Anesthesia

Volumn 24, Issue 1, 2012, Pages 78-79

  Hesselink, Jan M Keppel ^a   Kopsky, David J ^a  

^a Institute for Neuropathic Pain   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CANNABIS; COCODAMOL; KETAMINE; OXYCODONE; PREGABALIN;

ABNORMAL SENSATION; ADD ON THERAPY; ADULT; CASE REPORT; CUBITAL TUNNEL SYNDROME; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPESTHESIA; INTRACTABLE PAIN; LETTER; NERVE COMPRESSION; NEUROPATHIC PAIN; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; TRANSCUTANEOUS NERVE STIMULATION; UNSPECIFIED SIDE EFFECT;

ANALGESICS; CANNABIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KETAMINE; MIDDLE AGED; NEURALGIA; PAIN, INTRACTABLE; ULNAR NERVE COMPRESSION SYNDROMES;

EID: 84856318691     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2011.02.013     Document Type: Letter

References (11)

1. M. Backonja, G. Arndt, K.A. Gombar, B. Check, and M. Zimmermann Response of chronic neuropathic pain syndromes to ketamine: a preliminary study Pain 56 1994 51 57 (Pubitemid 24037259)
2. M.J. Sigtermans, J.J. van Hilten, and M.C. Bauer Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1 Pain 145 2009 304 311
3. D. Turcotte, J.A. Le Dorze, F. Esfahani, E. Frost, A. Gomori, and M. Namaka Examining the roles of cannabinoids in pain and other therapeutic indications: a review Expert Opin Pharmacother 11 2010 17 31
4. E.J. Rahn, and A.G. Hohmann Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside Neurotherapeutics 6 2009 713 737
5. S.K. Aggarwal, G.T. Carter, M.D. Sullivan, C. ZumBrunnen, R. Morrill, and J.D. Mayer Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State J Opioid Manag 5 2009 257 286
6. R.D. Hosking, and J.P. Zajicek Therapeutic potential of cannabis in pain medicine Br J Anaesth 101 2008 59 68 (Pubitemid 351881914)
7. J. Guidon, P. Beaulieu, and A.G. Hohmann Pharmacology of the cannabinoid system P. Beaulieu, D. Lussier, F. Porreca, A.H. Dickenson, Pharmacology of pain 1st edn 2010 IASP Press Seattle, WA 111 138
8. A.B. Petrenko, T. Yamakura, H. Baba, and K. Shimoji The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review Anesth Analg 97 2003 1108 1116 (Pubitemid 37158698)
9. K. Hirota, and D.G. Lambert Ketamine: its mechanism(s) of action and unusual clinical uses Br J Anaesth 77 1996 441 444 (Pubitemid 26341027)
10. I. Bushlin, R. Rozenfeld, and L.A. Devi Cannabinoid-opioid interactions during neuropathic pain and analgesia Curr Opin Pharmacol 10 2010 80 86
11. J.J. Feigenbaum, F. Bergmann, and S.A. Richmond Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker Proc Natl Acad Sci U S A 86 1989 9584 9587 (Pubitemid 20010472)